International medical firm GlaxoSmithKline is concerned that counterfeits of some of its products have been introduced into the Kenyan market by rogue pharmaceutical companies. The company’s Managing Director John Musunga said that fighting counterfeit products in the market has been challenging to the company. “Counterfeit products especially in the pharmaceutical field has been challenging so much,” said the director at the companies premises in Industrial area during a media visit.
